Novartis AG - Change To Inventory

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Change-To-Inventory" stands at -0.286 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2024.

Novartis AG's third quarter result of -0.128 Billion USD for the item "Change To Inventory" represents a decrease of -190.91 percent compared to it's second quarter result.

Also, Novartis AG's third quarter result of -0.128 Billion USD for the item "Change To Inventory" represents a decrease of -242.22 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Novartis AG's third quarter result of -0.286 Billion USD for the item "Change To Inventory" represents a decrease of -320.59 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.2692 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.2692 Billion United States Dollars.
The 3 year change is 0.116 Billion United States Dollars.
The 5 year change is 1.72 Billion United States Dollars.
The 10 year change is 0.22 Billion United States Dollars.

The Serie's long term average value is -0.701 Billion United States Dollars. It's latest available value, on 09/30/2025, is 0.415 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2020, to it's latest available value, on 09/30/2025, is +1.89 Billion.
The Serie's change in United States Dollars from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -0.5981 Billion.